M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer

Not Applicable

Completed

Conditions: Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Prognostic Stage IB Breast Cancer AJCC v8
Prognostic Stage II Breast Cancer AJCC v8
Prognostic Stage IIB Breast Cancer AJCC v8
Prognostic Stage III Breast Cancer AJCC v8
Anatomic Stage I Breast Cancer AJCC v8
Prognostic Stage IIA Breast Cancer AJCC v8
Prognostic Stage IIIA Breast Cancer AJCC v8
Prognostic Stage IIIB Breast Cancer AJCC v8

Interventions: Device: Actigraph
Other: Quality-of-Life Assessment
Other: Best Practice
Other: Questionnaire Administration
Other: Stretching
Procedure: Yoga
Other: Sleep Diary

First Posted Date: 2007-07-27

Last Posted Date: 2023-03-27

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 452

Registration Number: NCT00507923

Locations: 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States

Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection

Completed

Conditions: Head and Neck Cancer
Human Papillomavirus Infection
Oropharyngeal Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-27

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 252

Registration Number: NCT00508170

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors

Conditions: Kidney Neoplasms

Interventions: Procedure: 3 Tesla MRI Scan

First Posted Date: 2007-07-27

Last Posted Date: 2020-12-31

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 45

Registration Number: NCT00507884

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Sample Collection From Melanoma Patients

Terminated

Conditions: Melanoma

Interventions: Procedure: Blood Sample
Procedure: Tumor Sample

First Posted Date: 2007-07-26

Last Posted Date: 2022-09-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 131

Registration Number: NCT00507325

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin

Phase 1

Completed

Conditions: Liver Cancer
Advanced Solid Tumors

Interventions: Drug: Fluorouracil
Drug: Avastin
Drug: Leucovorin
Drug: Oxaliplatin

First Posted Date: 2007-07-26

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 63

Registration Number: NCT00507585

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Gastrointestinal Stromal Tumors (GIST) Registry

Completed

Conditions: Gastrointestinal Stromal Tumors

Interventions: Other: GIST Registry

First Posted Date: 2007-07-26

Last Posted Date: 2012-08-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 1800

Registration Number: NCT00507273

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Ambulatory Cancer Pain Management: A Feasibility Study

Completed

Conditions: Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-26

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 30

Registration Number: NCT00507351

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States
🇺🇸
Memorial Hermann Hospital, Houston, Texas, United States
🇺🇸
Michael E. DeBakey Veterans Administration Medical Center, Houston, Texas, United States

and more 1 locations

Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus

Phase 2

Completed

Conditions: Staphylococcus Aureus

Interventions: Drug: Daptomycin

First Posted Date: 2007-07-26

Last Posted Date: 2016-07-20

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 11

Registration Number: NCT00507247

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Pharmacogenetics, Emotional Reactivity and Smoking

Phase 2

Completed

Conditions: Tobacco Use Disorder
Smoking Cessation

Interventions: Drug: Placebo
Drug: Bupropion
Drug: Varenicline
Behavioral: Smoking Cessation Counseling

First Posted Date: 2007-07-26

Last Posted Date: 2021-05-06

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 646

Registration Number: NCT00507728

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions

Not Applicable

Completed

Conditions: Oral Cancer

Interventions: Procedure: Fluorescence Spectroscopy

First Posted Date: 2007-07-26

Last Posted Date: 2018-01-19

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 381

Registration Number: NCT00507182

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy